Literature DB >> 21543212

Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes.

Min-Yu Chung1, Hea Jin Park, Jose E Manautou, Sung I Koo, Richard S Bruno.   

Abstract

Oxidative and nitrative stress responses resulting from inflammation exacerbate liver injury associated with nonalcoholic steatohepatitis (NASH) by inducing lipid peroxidation and protein nitration. The objective of this study was to investigate whether the anti-inflammatory properties of green tea extract (GTE) would protect against NASH by suppressing oxidative and nitrative damage mediated by proinflammatory enzymes. Obese mice (ob/ob) and their 5-week-old C57BL6 lean littermates were fed 0%, 0.5% or 1% GTE for 6 weeks (n=12-13 mice/group). In obese mice, hepatic lipid accumulation, inflammatory infiltrates and serum alanine aminotransferase activity were markedly increased, whereas these markers of hepatic steatosis, inflammation and injury were significantly reduced among obese mice fed GTE. GTE also normalized hepatic 4-hydroxynonenal and 3-nitro-tyrosine (N-Tyr) concentrations to those observed in lean controls. These oxidative and nitrative damage markers were correlated with alanine aminotransferase (P<.05; r=0.410-0.471). Improvements in oxidative and nitrative damage by GTE were also associated with lower hepatic nicotinamide adenine dinucleotide phosphate oxidase activity. Likewise, GTE reduced protein expression levels of hepatic myeloperoxidase and inducible nitric oxide synthase and decreased the concentrations of nitric oxide metabolites. Correlative relationships between nicotinamide adenine dinucleotide phosphate oxidase and hepatic 4-hydroxynonenal (r=0.364) as well as nitric oxide metabolites and N-Tyr (r=0.598) suggest that GTE mitigates lipid peroxidation and protein nitration by suppressing the generation of reactive oxygen and nitrogen species. Further study is warranted to determine whether GTE can be recommended as an effective dietary strategy to reduce the risk of obesity-triggered NASH. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543212      PMCID: PMC3704146          DOI: 10.1016/j.jnutbio.2011.01.001

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  64 in total

1.  Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice.

Authors:  Inmaculada García-Ruiz; Cristina Rodríguez-Juan; Teresa Díaz-Sanjuan; Pilar del Hoyo; Francisco Colina; Teresa Muñoz-Yagüe; José A Solís-Herruzo
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

2.  Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.

Authors:  Joshua D Lambert; Mary J Kennett; Shengmin Sang; Kenneth R Reuhl; Jihyeung Ju; Chung S Yang
Journal:  Food Chem Toxicol       Date:  2009-10-31       Impact factor: 6.023

Review 3.  Pathogenesis of steatohepatitis.

Authors:  C P Day
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

4.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

6.  A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats.

Authors:  Michal Carmiel-Haggai; Arthur I Cederbaum; Natalia Nieto
Journal:  FASEB J       Date:  2004-11-02       Impact factor: 5.191

Review 7.  Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.

Authors:  Piero Portincasa; Ignazio Grattagliano; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Clin Biochem       Date:  2005-03       Impact factor: 3.281

Review 8.  Mitochondrial injury in steatohepatitis.

Authors:  Dominique Pessayre; Bernard Fromenty; Abdellah Mansouri
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-11       Impact factor: 2.566

Review 9.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

10.  Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell.

Authors:  Hirofumi Nishikawa; Keiji Wakano; Seiichi Kitani
Journal:  Biochem Biophys Res Commun       Date:  2007-08-09       Impact factor: 3.575

View more
  21 in total

1.  Green Tea Extract Treatment in Obese Mice with Nonalcoholic Steatohepatitis Restores the Hepatic Metabolome in Association with Limiting Endotoxemia-TLR4-NFκB-Mediated Inflammation.

Authors:  Geoffrey Y Sasaki; Jinhui Li; Morgan J Cichon; Ken M Riedl; Rachel E Kopec; Richard S Bruno
Journal:  Mol Nutr Food Res       Date:  2019-10-09       Impact factor: 5.914

2.  Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.

Authors:  Mozhdeh Sojoodi; Lan Wei; Derek J Erstad; Suguru Yamada; Tsutomu Fujii; Hadassa Hirschfield; Rosa S Kim; Gregory Y Lauwers; Michael Lanuti; Yujin Hoshida; Kenneth K Tanabe; Bryan C Fuchs
Journal:  Cancer Prev Res (Phila)       Date:  2020-04-06

Review 3.  Novel insights of dietary polyphenols and obesity.

Authors:  Shu Wang; Naima Moustaid-Moussa; Lixia Chen; Huanbiao Mo; Anuradha Shastri; Rui Su; Priyanka Bapat; InSook Kwun; Chwan-Li Shen
Journal:  J Nutr Biochem       Date:  2014-01       Impact factor: 6.048

4.  Effects of Different Green Teas on Obesity and Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.

Authors:  Dan-Dan Zhou; Qian-Qian Mao; Bang-Yan Li; Adila Saimaiti; Si-Yu Huang; Ruo-Gu Xiong; Ao Shang; Min Luo; Hang-Yu Li; Ren-You Gan; Hua-Bin Li; Sha Li
Journal:  Front Nutr       Date:  2022-06-24

5.  Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.

Authors:  Jia Xiao; Chi Tat Ho; Emily C Liong; Amin A Nanji; Tung Ming Leung; Thomas Yue Huen Lau; Man Lung Fung; George L Tipoe
Journal:  Eur J Nutr       Date:  2013-03-21       Impact factor: 5.614

6.  Green tea diet decreases PCB 126-induced oxidative stress in mice by up-regulating antioxidant enzymes.

Authors:  Bradley J Newsome; Michael C Petriello; Sung Gu Han; Margaret O Murphy; Katryn E Eske; Manjula Sunkara; Andrew J Morris; Bernhard Hennig
Journal:  J Nutr Biochem       Date:  2013-11-06       Impact factor: 6.048

7.  Epigallocatechin gallate does not accelerate the early phase of liver regeneration after partial hepatectomy in rats.

Authors:  Vojtěch Mezera; Otto Kučera; Alena Moravcová; Eva Peterová; Zuzana Červinková
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

Review 8.  Recent advances in the herbal treatment of non-alcoholic Fatty liver disease.

Authors:  Jia Xiao; Kwok Fai So; Emily C Liong; George L Tipoe
Journal:  J Tradit Complement Med       Date:  2013-04

9.  Focus on therapeutic strategies of nonalcoholic Fatty liver disease.

Authors:  Marilena Durazzo; Paola Belci; Alessandro Collo; Enrica Grisoglio; Simona Bo
Journal:  Int J Hepatol       Date:  2012-11-08

Review 10.  Functional roles of protein nitration in acute and chronic liver diseases.

Authors:  Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  Oxid Med Cell Longev       Date:  2014-04-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.